12-101157395-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_145913.5(SLC5A8):c.1717C>A(p.His573Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000246 in 1,594,572 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_145913.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC5A8 | NM_145913.5 | c.1717C>A | p.His573Asn | missense_variant | 15/15 | ENST00000536262.3 | NP_666018.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC5A8 | ENST00000536262.3 | c.1717C>A | p.His573Asn | missense_variant | 15/15 | 1 | NM_145913.5 | ENSP00000445340 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 151994Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000110 AC: 24AN: 218982Hom.: 0 AF XY: 0.000119 AC XY: 14AN XY: 117774
GnomAD4 exome AF: 0.000259 AC: 373AN: 1442578Hom.: 0 Cov.: 31 AF XY: 0.000239 AC XY: 171AN XY: 716240
GnomAD4 genome AF: 0.000125 AC: 19AN: 151994Hom.: 0 Cov.: 32 AF XY: 0.000162 AC XY: 12AN XY: 74216
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 06, 2022 | The c.1717C>A (p.H573N) alteration is located in exon 15 (coding exon 15) of the SLC5A8 gene. This alteration results from a C to A substitution at nucleotide position 1717, causing the histidine (H) at amino acid position 573 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at